Effect of Teriparatide, Alendronate, and Zoledronic Acid on treatment of secondary osteoporosis
Phase 2
- Conditions
- Secondary osteoporosis.Osteoporosis with pathological fracture
- Registration Number
- IRCT201605159014N98
- Lead Sponsor
- Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
(a) secondary osteoporosis; (b) T-score less than -2.5 in the lumbar spine or femoral neck.
Exclusion criteria: (a) primary osteoporosis; (b) using prednisolone more than 3 months; (c) rheumatologic disease; (d) malignancy; (e) hypothyroidism; (f) renal failure; (g) history of surgery of parathyroid gland.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessing the bone density. Timepoint: before treatment and one year later. Method of measurement: using Dual X-ray Absorptiometry.
- Secondary Outcome Measures
Name Time Method Assessing the bone density. Timepoint: before treatment and one year later. Method of measurement: using T-score.